Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/24872| Title: | Immune therapies in ulcerative colitis: are we beyond anti-TNF yet? | Austin Authors: | Raine, Tim;Verstockt, Bram;De Cruz, Peter P | Affiliation: | Department of Gastroenterology, Cambridge University Teaching Hospitals NHS Foundation Trust, Cambridge, UK Department of Gastroenterology and Hepatology, University Hospitals Leuven and Department of Chronic Diseases, Metabolism and Ageing, Translational Research Center for Gastrointestinal Disorders (TARGID-IBD), KU Leuven, Leuven, Belgium Gastroenterology and Hepatology |
Issue Date: | Sep-2020 | Date: | 2020-09 | Publication information: | The Lancet. Gastroenterology & Hepatology 2020; 5(9): 794-796 | URI: | https://ahro.austin.org.au/austinjspui/handle/1/24872 | DOI: | 10.1016/S2468-1253(20)30210-7 | Journal: | The Lancet. Gastroenterology & Hepatology | PubMed URL: | 32818453 | Type: | Journal Article |
| Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.